UniProt ID | CTIF_HUMAN | |
---|---|---|
UniProt AC | O43310 | |
Protein Name | CBP80/20-dependent translation initiation factor | |
Gene Name | CTIF | |
Organism | Homo sapiens (Human). | |
Sequence Length | 598 | |
Subcellular Localization | Cytoplasm, perinuclear region . | |
Protein Description | Specifically required for the pioneer round of mRNA translation mediated by the cap-binding complex (CBC), that takes place during or right after mRNA export via the nuclear pore complex (NPC). Acts via its interaction with the NCBP1/CBP80 component of the CBC complex and recruits the 40S small subunit of the ribosome via eIF3. In contrast, it is not involved in steady state translation, that takes place when the CBC complex is replaced by cytoplasmic cap-binding protein eIF4E. Also required for nonsense-mediated mRNA decay (NMD), the pioneer round of mRNA translation mediated by the cap-binding complex playing a central role in nonsense-mediated mRNA decay (NMD).. | |
Protein Sequence | MENSSAASASSEAGSSRSQEIEELERFIDSYVLEYQVQGLLADKTEGDGESERTQSHISQWTADCSEPLDSSCSFSRGRAPPQQNGSKDNSLDMLGTDIWAANTFDSFSGATWDLQPEKLDFTQFHRKVRHTPKQPLPHIDREGCGKGKLEDGDGINLNDIEKVLPAWQGYHPMPHEVEIAHTKKLFRRRRNDRRRQQRPPGGNKPQQHGDHQPGSAKHNRDHQKSYQGGSAPHPSGRPTHHGYSQNRRWHHGNMKHPPGDKGEAGAHRNAKETMTIENPKLEDTAGDTGHSSLEAPRSPDTLAPVASERLPPQQSGGPEVETKRKDSILPERIGERPKITLLQSSKDRLRRRLKEKDEVAVETTTPQQNKMDKLIEILNSMRNNSSDVDTKLTTFMEEAQNSTNSEEMLGEIVRTIYQKAVSDRSFAFTAAKLCDKMALFMVEGTKFRSLLLNMLQKDFTVREELQQQDVERWLGFITFLCEVFGTMRSSTGEPFRVLVCPIYTCLRELLQSQDVKEDAVLCCSMELQSTGRLLEEQLPEMMTELLASARDKMLCPSESMLTRSLLLEVIELHANSWNPLTPPITQYYNRTIQKLTA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MENSSAAS -------CCCCCHHH | 11.25 | 22814378 | |
4 | Phosphorylation | ----MENSSAASASS ----CCCCCHHHHCC | 14.19 | 27251275 | |
5 | Phosphorylation | ---MENSSAASASSE ---CCCCCHHHHCCC | 39.16 | 28450419 | |
8 | Phosphorylation | MENSSAASASSEAGS CCCCCHHHHCCCCCC | 28.53 | 28450419 | |
10 | Phosphorylation | NSSAASASSEAGSSR CCCHHHHCCCCCCCC | 26.64 | 28450419 | |
11 | Phosphorylation | SSAASASSEAGSSRS CCHHHHCCCCCCCCH | 31.05 | 28450419 | |
15 | Phosphorylation | SASSEAGSSRSQEIE HHCCCCCCCCHHHHH | 29.62 | 28450419 | |
16 | Phosphorylation | ASSEAGSSRSQEIEE HCCCCCCCCHHHHHH | 34.73 | 28450419 | |
18 | Phosphorylation | SEAGSSRSQEIEELE CCCCCCCHHHHHHHH | 33.83 | 23401153 | |
35 | Phosphorylation | IDSYVLEYQVQGLLA HHHHHHHHHHHHHHC | 15.15 | 28796482 | |
71 | Phosphorylation | DCSEPLDSSCSFSRG CCCCCCCCCCCCCCC | 40.71 | 28857561 | |
72 | Phosphorylation | CSEPLDSSCSFSRGR CCCCCCCCCCCCCCC | 17.28 | 28857561 | |
74 | Phosphorylation | EPLDSSCSFSRGRAP CCCCCCCCCCCCCCC | 28.36 | 23186163 | |
123 | Phosphorylation | QPEKLDFTQFHRKVR CHHHCCHHHHHHHCC | 29.96 | 29978859 | |
216 | Phosphorylation | HGDHQPGSAKHNRDH CCCCCCCCCCCCCCC | 40.61 | 28555341 | |
226 | Phosphorylation | HNRDHQKSYQGGSAP CCCCCCHHCCCCCCC | 19.00 | - | |
274 | Phosphorylation | AHRNAKETMTIENPK CCCCCCCCEEEECCC | 20.93 | 23186163 | |
276 | Phosphorylation | RNAKETMTIENPKLE CCCCCCEEEECCCHH | 32.34 | 23186163 | |
285 | Phosphorylation | ENPKLEDTAGDTGHS ECCCHHCCCCCCCCC | 24.14 | 23403867 | |
289 | Phosphorylation | LEDTAGDTGHSSLEA HHCCCCCCCCCCCCC | 35.56 | 23927012 | |
292 | Phosphorylation | TAGDTGHSSLEAPRS CCCCCCCCCCCCCCC | 37.65 | 23927012 | |
293 | Phosphorylation | AGDTGHSSLEAPRSP CCCCCCCCCCCCCCC | 25.26 | 23927012 | |
299 | Phosphorylation | SSLEAPRSPDTLAPV CCCCCCCCCCCCCCH | 26.52 | 19664994 | |
302 | Phosphorylation | EAPRSPDTLAPVASE CCCCCCCCCCCHHHC | 28.36 | 30266825 | |
308 | Phosphorylation | DTLAPVASERLPPQQ CCCCCHHHCCCCCCC | 24.39 | 22167270 | |
328 | Phosphorylation | VETKRKDSILPERIG CCCCCCCCCCHHHCC | 29.12 | 28102081 | |
364 | Phosphorylation | KDEVAVETTTPQQNK HCCHHEECCCCCCCH | 29.39 | 22210691 | |
365 | Phosphorylation | DEVAVETTTPQQNKM CCHHEECCCCCCCHH | 23.99 | 22210691 | |
366 | Phosphorylation | EVAVETTTPQQNKMD CHHEECCCCCCCHHH | 26.90 | 21815630 | |
458 | Acetylation | LLLNMLQKDFTVREE HHHHHHHCCCCHHHH | 51.34 | 7976049 | |
544 | Phosphorylation | EQLPEMMTELLASAR HHHHHHHHHHHHHHH | 23.36 | 29888752 | |
549 | Phosphorylation | MMTELLASARDKMLC HHHHHHHHHHHHCCC | 24.65 | 29888752 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CTIF_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CTIF_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CTIF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of CTIF_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-16 AND SER-18, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-16 AND SER-18, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND MASSSPECTROMETRY. |